Press Releases Ypsomed Group

Burgdorf – Ypsomed has recruited two experienced diabetes care executives to boost its diabetes treatment product franchise.

Press Releases Ypsomed Group

Burgdorf – In the past 2011/12 business year, the Ypsomed Group increased net profit by 55.5% to CHF 8.5 million, which was positively affected by the sale of financial assets.

Press Releases Ypsomed Group

Burgdorf – Ypsomed is expanding its mylife product range with the innovative self-injection system mylife DailyDose.

Press Releases Ypsomed Group

Burgdorf - SYpsomed has taken notice that Sanofi-Aventis has filed a lawsuit in Basel against Ypsomed AG and TecPharma Licensing AG in relation to the SoloStar injection system developed and manufactured by Sanofi-Aventis. The lawsuit claims certain license rights, which in the opinion of Sanofi-Aventis should be granted by Ypsomed.

Press Releases Ypsomed Group

Burgdorf - Sanofi-Aventis has confirmed the order volumes for calendar year 2008 for the successfully launched and established pen systems: OptiSet, OptiClik and OptiPen Pro. Richard Fritschi, Ypsomed CEO, is pleased: “The confirmed orders for 2008 by Sanofi-Aventis are within our expectations, but - as announced earlier - lower than in the past year.